Dorrell L et al. |
Toxicity of clarithromycin in the treatment of Mycobacterium avium complex infection in a patient with AIDS. |
1994 |
J. Antimicrob. Chemother. |
pmid:7868416
|
Funke G et al. |
Development of resistance to macrolide antibiotics in an AIDS patient treated with clarithromycin for Campylobacter jejuni diarrhea. |
1994 |
Eur. J. Clin. Microbiol. Infect. Dis. |
pmid:7805694
|
Fujii R et al. |
[Clinical studies on clarithromycin dry syrup in the pediatric field. Pediatric Study Group of TE-031 Dry Syrup]. |
1994 |
Jpn J Antibiot |
pmid:7807690
|
Bonnet E et al. |
Clarithromycin: a potent agent against infections due to Mycobacterium marinum. |
1994 |
Clin. Infect. Dis. |
pmid:8038339
|
Lemmen SW et al. |
Bactericidal activity of clarithromycin and cefaclor against Streptococcus pneumoniae and Moraxella catarrhalis in healthy volunteers. |
1994 |
J. Antimicrob. Chemother. |
pmid:8040139
|
Dautzenberg B et al. |
[Treatment with clarithromycin of 173 HIV+ patients with disseminated Mycobacterium avium intracellulare infection]. |
1994 |
Rev Mal Respir |
pmid:8041990
|
Böttger EC |
Resistance to drugs targeting protein synthesis in mycobacteria. |
1994 |
Trends Microbiol. |
pmid:7850212
|
al-Assi MT et al. |
Clarithromycin, tetracycline, and bismuth: a new non-metronidazole therapy for Helicobacter pylori infection. |
1994 |
Am. J. Gastroenterol. |
pmid:8053435
|
Guelar A et al. |
[Therapeutic alternatives for cases of cerebral toxoplasmosis in patients with AIDS: clarithromycin and atovaquone]. |
1994 |
Enferm. Infecc. Microbiol. Clin. |
pmid:8011719
|
Aspin MM et al. |
Comparative study of the safety and efficacy of clarithromycin and amoxicillin-clavulanate in the treatment of acute otitis media in children. |
1994 |
J. Pediatr. |
pmid:8021763
|
Chaisson RE et al. |
Clarithromycin therapy for bacteremic Mycobacterium avium complex disease. A randomized, double-blind, dose-ranging study in patients with AIDS. AIDS Clinical Trials Group Protocol 157 Study Team. |
1994 |
Ann. Intern. Med. |
pmid:7978715
|
Goldberger M and Masur H |
Clarithromycin therapy for Mycobacterium avium complex disease in patients with AIDS: potential and problems. |
1994 |
Ann. Intern. Med. |
pmid:7978725
|
Ohgaki N |
Bacterial biofilm in chronic airway infection. |
1994 |
Kansenshogaku Zasshi |
pmid:8138670
|
Chan GP et al. |
Clinical trial of clarithromycin for lepromatous leprosy. |
1994 |
Antimicrob. Agents Chemother. |
pmid:8203847
|
Onyeji CO et al. |
Efficacies of liposome-encapsulated clarithromycin and ofloxacin against Mycobacterium avium-M. intracellulare complex in human macrophages. |
1994 |
Antimicrob. Agents Chemother. |
pmid:8203849
|
Bermudez LE et al. |
Clarithromycin, dapsone, and a combination of both used to treat or prevent disseminated Mycobacterium avium infection in beige mice. |
1994 |
Antimicrob. Agents Chemother. |
pmid:7695252
|
Mor N et al. |
Effects of clarithromycin and rifabutin alone and in combination on intracellular and extracellular replication of Mycobacterium avium. |
1994 |
Antimicrob. Agents Chemother. |
pmid:7695255
|
Calì G et al. |
[Clarithromycin in the treatment of oral infections]. |
1994 |
Minerva Stomatol |
pmid:7700226
|
Jones RN et al. |
Validation of NCCLS macrolide (azithromycin, clarithromycin, and erythromycin) interpretive criteria for Haemophilus influenzae tested with the Haemophilus test medium. National Committee for Clinical Laboratory Standards. |
1994 |
Diagn. Microbiol. Infect. Dis. |
pmid:7924221
|
Kanatani MS and Guglielmo BJ |
The new macrolides. Azithromycin and clarithromycin. |
1994 |
West. J. Med. |
pmid:8128699
|
|
Antibiotic gets FDA nod for MAC treatment. |
1994 |
Am J Nurs |
pmid:8304386
|
Ji B et al. |
Effectiveness of various antimicrobial agents against Mycobacterium avium complex in the beige mouse model. |
1994 |
Antimicrob. Agents Chemother. |
pmid:7872741
|
Skinner PS et al. |
A bone marrow-derived murine macrophage model for evaluating efficacy of antimycobacterial drugs under relevant physiological conditions. |
1994 |
Antimicrob. Agents Chemother. |
pmid:7872747
|
Valero G et al. |
Activities of clarithromycin, ofloxacin, and clarithromycin plus ethambutol against Mycobacterium simiae in murine model of disseminated infection. |
1994 |
Antimicrob. Agents Chemother. |
pmid:7872769
|
Yamada S et al. |
[A child with iritis due to Chlamydia pneumoniae infection]. |
1994 |
Kansenshogaku Zasshi |
pmid:7876679
|
Wüst J and Hardegger U |
Penetration of clarithromycin into human saliva. |
1993 Sep-Oct |
Chemotherapy |
pmid:8370320
|
Scaglione F et al. |
A new model examining intracellular and extracellular activity of amoxicillin, azithromycin, and clarithromycin in infected cells. |
1993 Nov-Dec |
Chemotherapy |
pmid:8222870
|
Ohmori S et al. |
Effects of clarithromycin and its metabolites on the mixed function oxidase system in hepatic microsomes of rats. |
1993 Mar-Apr |
Drug Metab. Dispos. |
pmid:8097709
|
Wallace RJ et al. |
Drug intolerance to high-dose clarithromycin among elderly patients. |
1993 Mar-Apr |
Diagn. Microbiol. Infect. Dis. |
pmid:8477575
|
Adam D |
Clarithromycin 250 mg b.i.d. for 5 or 10 days in the treatment of adult patients with purulent bronchitis. |
1993 Jul-Aug |
Infection |
pmid:8225636
|
Coles SJ et al. |
A comparative study of clarithromycin and amoxycillin suspensions in the treatment of pediatric patients with acute otitis media. |
1993 Jul-Aug |
Infection |
pmid:8225637
|
Miller CA |
Infections, resistant microbes, and older adults. |
1993 Jan-Feb |
Geriatr Nurs |
pmid:8383085
|
Ritchie DJ et al. |
In vitro activity of clarithromycin, cefprozil, and other common oral antimicrobial agents against gram-positive and gram-negative pathogens. |
1993 Jan-Feb |
Clin Ther |
pmid:8458040
|
Albani F et al. |
Clarithromycin-carbamazepine interaction: a case report. |
1993 Jan-Feb |
Epilepsia |
pmid:8422851
|
Sader HS et al. |
In vitro activity of cefpodoxime compared with other oral cephalosporins tested against 5556 recent clinical isolates from five medical centers. |
1993 Aug-Sep |
Diagn. Microbiol. Infect. Dis. |
pmid:8243035
|
De Wit S et al. |
Acquired resistance to clarithromycin as combined therapy in Mycobacterium avium intracellulare infection. |
1993 |
Lancet |
pmid:8093299
|
Maurin M and Raoult D |
In vitro susceptibilities of spotted fever group rickettsiae and Coxiella burnetti to clarithromycin. |
1993 |
Antimicrob. Agents Chemother. |
pmid:8109928
|
|
Clarithromycin effectively treats infection in AIDS patients. |
1993 |
Oncology (Williston Park, N.Y.) |
pmid:8512782
|
Clark JA and Margolis DM |
A cutaneous lesion in a patient with AIDS: an unusual presentation of infection due to Mycobacterium avium complex. |
1993 |
Clin. Infect. Dis. |
pmid:8513064
|
Alba D et al. |
[Clarithromycin in the treatment of cerebral toxoplasmosis associated with HIV infection]. |
1993 |
Rev Clin Esp |
pmid:8516514
|
Alder J et al. |
Clarithromycin therapy of experimental Treponema pallidum infections in hamsters. |
1993 |
Antimicrob. Agents Chemother. |
pmid:8494384
|
Humphreys JE et al. |
A clarithromycin sensitivity survey in the United Kingdom using Stokes' method. |
1993 |
J. Antimicrob. Chemother. |
pmid:8226438
|
Franck N et al. |
Treatment of Mycobacterium chelonae-induced skin infection with clarithromycin. |
1993 |
J. Am. Acad. Dermatol. |
pmid:8496448
|
Scaglione F et al. |
Immunostimulation by clarithromycin in healthy volunteers and chronic bronchitis patients. |
1993 |
J Chemother |
pmid:8229150
|
Tomioka H et al. |
[In vitro antimycobacterial activity of clarithromycin and its therapeutic efficacy against Mycobacterium intracellulare infection induced in mice]. |
1993 |
Kekkaku |
pmid:8497119
|
Monteforte JS and Wood CA |
Pneumonia caused by Nocardia nova and Aspergillus fumigatus after cardiac transplantation. |
1993 |
Eur. J. Clin. Microbiol. Infect. Dis. |
pmid:8500477
|
Andrews J and Wise R |
Disk susceptibility testing for clarithromycin. |
1993 |
Eur. J. Clin. Microbiol. Infect. Dis. |
pmid:8187799
|
Hakkarinen WD |
Clarithromycin vs penicillin. |
1993 |
J Fam Pract |
pmid:8482929
|
Granier H et al. |
[Mycobacterium chelonei arthritis in an immunosuppressed patient. Efficacy of the treatment with clarithromycin]. |
1993 |
Ann Med Interne (Paris) |
pmid:8141516
|
MacGowan AR et al. |
Synergy testing of macrolide combinations using the chequerboard technique. |
1993 |
J. Antimicrob. Chemother. |
pmid:8144439
|
Ximenes E et al. |
[Ciprofloxacin, clarithromycin, rifampin: in vitro bactericidal activity of double and triple drug combinations against strains of atypical mycobacteria]. |
1993 |
Pathol. Biol. |
pmid:8233629
|
Peterson WL et al. |
Clarithromycin as monotherapy for eradication of Helicobacter pylori: a randomized, double-blind trial. |
1993 |
Am. J. Gastroenterol. |
pmid:8237933
|
Romand S et al. |
In vitro and in vivo activities of the hydroxynaphthoquinone atovaquone alone or combined with pyrimethamine, sulfadiazine, clarithromycin, or minocycline against Toxoplasma gondii. |
1993 |
Antimicrob. Agents Chemother. |
pmid:8285620
|
Yasuda H et al. |
Interaction between biofilms formed by Pseudomonas aeruginosa and clarithromycin. |
1993 |
Antimicrob. Agents Chemother. |
pmid:8239580
|
Schmidt T et al. |
Clarithromycin lacks bactericidal activity in cerebrospinal fluid in experimental pneumococcal meningitis. |
1993 |
J. Antimicrob. Chemother. |
pmid:8288505
|
Dautzenberg B et al. |
Clarithromycin and other antimicrobial agents in the treatment of disseminated Mycobacterium avium infections in patients with acquired immunodeficiency syndrome. |
1993 |
Arch. Intern. Med. |
pmid:8427539
|
Walker LL et al. |
Clarithromycin is bactericidal against strains of Mycobacterium leprae resistant and susceptible to dapsone and rifampin. |
1993 |
Int. J. Lepr. Other Mycobact. Dis. |
pmid:8326182
|
Alder J et al. |
Efficacy of clarithromycin for treatment of experimental Lyme disease in vivo. |
1993 |
Antimicrob. Agents Chemother. |
pmid:8328782
|
Mor N and Heifets L |
Inhibition of intracellular growth of Mycobacterium avium by one pulsed exposure of infected macrophages to clarithromycin. |
1993 |
Antimicrob. Agents Chemother. |
pmid:8328792
|
Lazard T et al. |
Clarithromycin, minocycline, and rifabutin treatments before and after infection of C57BL/6 mice with Mycobacterium avium. |
1993 |
Antimicrob. Agents Chemother. |
pmid:8215285
|
Helm CJ et al. |
Comparison of topical antibiotics for treating Mycobacterium fortuitum keratitis in an animal model. |
1993 |
Am. J. Ophthalmol. |
pmid:8250072
|
Green PA et al. |
Mycobacterium avium complex parotid lymphadenitis: successful therapy with clarithromycin and ethambutol. |
1993 |
Pediatr. Infect. Dis. J. |
pmid:8346008
|
Pialoux G et al. |
Combination antibiotic treatment with clarithromycin for human immunodeficiency virus-associated Rhodococcus equi infection. |
1993 |
Clin. Infect. Dis. |
pmid:8218702
|
|
Clinical Perspectives on Clarithromycin in Pediatric Infections. Symposium proceedings. February 19-20, 1993. |
1993 |
Pediatr. Infect. Dis. J. |
pmid:7905199
|
Foltzer MA et al. |
Bronchopulmonary bacillary angiomatosis. |
1993 |
Chest |
pmid:8365330
|
Fraschini F et al. |
Clarithromycin clinical pharmacokinetics. |
1993 |
Clin Pharmacokinet |
pmid:8222460
|
Neu HC and Chick TW |
Efficacy and safety of clarithromycin compared to cefixime as outpatient treatment of lower respiratory tract infections. |
1993 |
Chest |
pmid:8222794
|
Sedlmayr T et al. |
[Clarithromycin, a new macrolide antibiotic. Effectiveness in puerperal infections and pharmacokinetics in breast milk]. |
1993 |
Geburtshilfe Frauenheilkd |
pmid:8370491
|
Kodama R et al. |
[Eradication therapy of Helicobacter pylori in gastroduodenal ulcer and its long-term course]. |
1993 |
Nippon Rinsho |
pmid:8283646
|
Ji B et al. |
Powerful bactericidal activities of clarithromycin and minocycline against Mycobacterium leprae in lepromatous leprosy. |
1993 |
J. Infect. Dis. |
pmid:8257487
|
Scaglione F et al. |
The postantibiotic effect of clarithromycin and its major human metabolite, 14-hydroxy clarithromycin. |
1993 |
J. Antimicrob. Chemother. |
pmid:8262876
|
Guay DR and Craft JC |
Overview of the pharmacology of clarithromycin suspension in children and a comparison with that in adults. |
1993 |
Pediatr. Infect. Dis. J. |
pmid:8295810
|
Hebert AA et al. |
Comparative safety and efficacy of clarithromycin and cefadroxil suspensions in the treatment of mild to moderate skin and skin structure infections in children. |
1993 |
Pediatr. Infect. Dis. J. |
pmid:8295811
|
Pukander JS et al. |
Clarithromycin vs. amoxicillin suspensions in the treatment of pediatric patients with acute otitis media. |
1993 |
Pediatr. Infect. Dis. J. |
pmid:8295812
|
Dubois J et al. |
Efficacy of clarithromycin vs. amoxicillin/clavulanate in the treatment of acute maxillary sinusitis. |
1993 |
Ear Nose Throat J |
pmid:8313865
|
Nasu M |
[Helicobacter pylori infections]. |
1993 |
Nippon Naika Gakkai Zasshi |
pmid:8315343
|
Braga PC and Piatti G |
Sub-lethal concentrations of clarithromycin interfere with the expression of Staphylococcus aureus adhesiveness to human cells. |
1993 |
J Chemother |
pmid:8371124
|
Macklin JL et al. |
A single-blind, randomised, comparative study of clarithromycin and amoxycillin suspensions in the treatment of children with lower respiratory tract infections. |
1993 |
J Chemother |
pmid:8371127
|
Ragnaud JM et al. |
[Cerebral toxoplasmosis in AIDS. 73 cases. Clinical Epidemiology Group on AIDS in Aquitania]. |
1993 |
Presse Med |
pmid:8378280
|
Hoffner SE et al. |
Susceptibility of Mycobacterium malmoense to antibacterial drugs and drug combinations. |
1993 |
Antimicrob. Agents Chemother. |
pmid:8392308
|
Gevaudan MJ et al. |
In-vitro evaluation of clarithromycin, temafloxacin, and ethambutol in combination against Mycobacterium avium complex. |
1993 |
J. Antimicrob. Chemother. |
pmid:8392998
|
Wallace RJ et al. |
Clinical trial of clarithromycin for cutaneous (disseminated) infection due to Mycobacterium chelonae. |
1993 |
Ann. Intern. Med. |
pmid:8357113
|
Wettengel R et al. |
Clarithromycin versus cefaclor for the treatment of mild-to-moderate acute bacterial bronchitis. |
1993 |
J. Antimicrob. Chemother. |
pmid:8360133
|
Nakashio S et al. |
[Antimicrobial activity of clarithromycin and its effect on bacterial adherence to medical material]. |
1993 |
Jpn J Antibiot |
pmid:8360978
|
Lonks JR and Medeiros AA |
High rate of erythromycin and clarithromycin resistance among Streptococcus pneumoniae isolates from blood cultures from Providence, R.I. |
1993 |
Antimicrob. Agents Chemother. |
pmid:8239578
|
Mor N and Heifets L |
MICs and MBCs of clarithromycin against Mycobacterium avium within human macrophages. |
1993 |
Antimicrob. Agents Chemother. |
pmid:8431006
|
Klopman G et al. |
Anti-Mycobacterium avium activity of quinolones: in vitro activities. |
1993 |
Antimicrob. Agents Chemother. |
pmid:8239587
|
Tomioka H et al. |
In vitro antimicrobial activity of benzoxazinorifamycin, KRM-1648, against Mycobacterium avium complex, determined by the radiometric method. |
1993 |
Antimicrob. Agents Chemother. |
pmid:8431020
|
Chu SY et al. |
Effect of moderate or severe hepatic impairment on clarithromycin pharmacokinetics. |
1993 |
J Clin Pharmacol |
pmid:8331208
|
Graham DY et al. |
Clarithromycin for the eradication of Helicobacter pylori. |
1993 |
J. Clin. Gastroenterol. |
pmid:8331260
|
Esvant H et al. |
[Primary prophylaxis of cerebral toxoplasmosis in AIDS with clarithromycin]. |
1993 |
Presse Med |
pmid:8337221
|
Lederer J et al. |
Clarithromycin treatment of posttraumatic Mycobacterium fortuitum wound infection. |
1993 |
Pediatr. Infect. Dis. J. |
pmid:8414785
|
Guay DR et al. |
Overview of the tolerability profile of clarithromycin in preclinical and clinical trials. |
1993 |
Drug Saf |
pmid:8504017
|
de Vega T et al. |
Clarithromycin-induced leukocytoclastic vasculitis. |
1993 |
Eur. J. Clin. Microbiol. Infect. Dis. |
pmid:8404922
|
Chu S et al. |
Single- and multiple-dose pharmacokinetics of clarithromycin, a new macrolide antimicrobial. |
1993 |
J Clin Pharmacol |
pmid:8408732
|
Dever LL et al. |
Comparative in vitro activities of clarithromycin, azithromycin, and erythromycin against Borrelia burgdorferi. |
1993 |
Antimicrob. Agents Chemother. |
pmid:8215288
|
Barradell LB et al. |
Clarithromycin. A review of its pharmacological properties and therapeutic use in Mycobacterium avium-intracellulare complex infection in patients with acquired immune deficiency syndrome. |
1993 |
Drugs |
pmid:7691518
|
Heifets L et al. |
Mycobacterium avium strains resistant to clarithromycin and azithromycin. |
1993 |
Antimicrob. Agents Chemother. |
pmid:8031351
|
Fass RJ |
Erythromycin, clarithromycin, and azithromycin: use of frequency distribution curves, scattergrams, and regression analyses to compare in vitro activities and describe cross-resistance. |
1993 |
Antimicrob. Agents Chemother. |
pmid:8257127
|
Watanabe Y et al. |
Chemical modification of erythromycins. XII. A facile synthesis of clarithromycin (6-O-methylerythromycin A) via 2'-silylethers of erythromycin A derivatives. |
1993 |
J. Antibiot. |
pmid:8360112
|